Novel use of (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylme thylaminomethyl)- chromane and its physiologically acCeptable salts

Details for Australian Patent Application No. 2001230222 (hide)

Owner Merck Patent GmbH

Inventors Weber, Frank; Seyfried, Christoph; Russ, Hermann; Bartoszyk, Gerd

Agent Davies Collison Cave

Pub. Number AU-B-2001230222

PCT Pub. Number WO01/68063

Priority 00104531 10.03.00 EP

Filing date 1 February 2001

Wipo publication date 24 September 2001

Acceptance publication date 17 March 2005

International Classifications

A61K 031/00

Event Publications

17 March 2005 Application Accepted

  Published as AU-B-2001230222

12 May 2005 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 07 Apr 2005. Address for service in Australia - Davies Collison Cave Level 10 10 Barrack Street Sydney NSW 2000

14 July 2005 Standard Patent Sealed

22 September 2005 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 07 Apr 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001230224

2001230221